Kromek Group PLC Director Share Purchase (6349L)
16 May 2022 - 9:07PM
UK Regulatory
TIDMKMK
RNS Number : 6349L
Kromek Group PLC
16 May 2022
16 May 2022
Kromek Group plc
("Kromek" or the "Group")
Director Share Purchase
Kromek (AIM: KMK), a leading developer of radiation and
bio-detection technology solutions for the advanced imaging and
CBRN detection segments, announces that Rakesh Sharma,
Non-Executive Chairman, has today purchased 338,344 ordinary shares
of 1 pence each in the Group ("Ordinary Shares") at a price of 8.87
pence per Ordinary Share.
Following this purchase, Mr Sharma has an interest in 807,539
Ordinary Shares, representing 0.19% of the issued share capital of
the Group.
For further information, please contact:
Kromek Group plc
Arnab Basu, CEO
Paul Farquhar, CFO +44 (0)1740 626 060
finnCap Ltd (Nominated Adviser and Broker)
Geoff Nash/Kate Bannatyne/George Dollemore
- Corporate Finance +44 (0)20 7220 0500
Tim Redfern/Charlotte Sutcliffe - ECM
Luther Pendragon (Financial PR)
Harry Chathli/Claire Norbury +44 (0)20 7618 9100
About Kromek Group plc
Kromek Group plc is a leading developer of radiation detection
and bio-detection technology solutions for the advanced imaging and
CBRN detection segments. Headquartered in County Durham, UK, Kromek
has manufacturing operations in the UK and US, delivering on the
vision of enhancing the quality of life through innovative
detection technology solutions.
The advanced imaging segment comprises the medical (including CT
and SPECT), security and industrial markets. Kromek provides its
OEM customers with detector components, based on its core cadmium
zinc telluride (CZT) platform, to enable better detection of
diseases such as cancer and Alzheimer's, contamination in
industrial manufacture and explosives in aviation settings.
In CBRN detection, the Group provides nuclear radiation
detection solutions to the global homeland defence and security
market. Kromek's compact, handheld, high-performance radiation
detectors, based on advanced scintillation technology, are
primarily used to protect critical infrastructure and urban
environments from the threat of 'dirty bombs'.
The Group is also developing bio-security solutions in the CBRN
detection segment. These consist of fully automated and autonomous
systems to detect a wide range of airborne pathogens.
Kromek is listed on AIM, a market of the London Stock Exchange,
under the trading symbol 'KMK'.
Further information is available at www.kromek.com .
The information contained within this announcement is deemed to
constitute inside information as stipulated under the retained EU
law version of the Market Abuse Regulation (EU) No. 596/2014 (the
"UK MAR") which is part of UK law by virtue of the European Union
(Withdrawal) Act 2018. The information is disclosed in accordance
with the Company's obligations under Article 17 of the UK MAR. Upon
the publication of this announcement, this inside information is
now considered to be in the public domain.
The Group makes the following disclosures in accordance with
article 19(3) of the Market Abuse Regulation:
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Rakesh Sharma
--------------------------- -----------------------------------
2 Reason for the notification
----------------------------------------------------------------
a) Position/status Non-Executive Chairman
--------------------------- -----------------------------------
b) Initial notification Initial notification
/Amendment
--------------------------- -----------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------
a) Name Kromek Group plc
--------------------------- -----------------------------------
b) LEI 213800VLHYXGHEX5VQ48
--------------------------- -----------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
----------------------------------------------------------------
a) Description Ordinary Shares of 1p each
of the financial
instrument,
type of instrument GB00BD7V5D43
Identification
code
--------------------------- -----------------------------------
b) Nature of Purchase of Ordinary Shares
the transaction
--------------------------- -----------------------------------
c) Price(s) Price(s) Volume(s)
and volume(s) 8.87 pence 338,344
----------
--------------------------- -----------------------------------
d) Aggregated
information N/A
- Aggregated
volume
- Price
--------------------------- -----------------------------------
e) Date of the 16 May 2022
transaction
--------------------------- -----------------------------------
f) Place of London Stock Exchange
the transaction
--------------------------- -----------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHEAFSKFEKAEFA
(END) Dow Jones Newswires
May 16, 2022 07:07 ET (11:07 GMT)
Kromek (LSE:KMK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kromek (LSE:KMK)
Historical Stock Chart
From Apr 2023 to Apr 2024
